S&P Downgrades ImClone

Plus analysts' opinions on Genentech, Wal-Mart, and more

ImClone (IMCL ): Downgrades to 4 STARS (buy) from 5 STARS (strong buy)

To continue reading this article you must be a Bloomberg Professional Service Subscriber.